Efficacy and safety of ocrelizumab vs interferon beta-1a in participants of African descent with relapsing multiple sclerosis in the Phase III OPERA I and OPERA II studies

Publication date: Available online 7 May 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Bruce A.C. Cree, Ashish Pradhan, Jinglan Pei, Mitzi J. Williams, OPERA I and OPERA II clinical investigators
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research